UK Government's Vascular Screening Programme's Flaws

Editor's Choice
Main Category: Vascular
Also Included In: Primary Care / General Practice;  Public Health;  Cardiovascular / Cardiology
Article Date: 01 Mar 2009 - 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  


Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


The UK Government's vascular screening programme will most likely misclassify risk in hundreds of thousands of patients and worsen health inequalities, according to research published in the journal Pulse.

Primary Care Trusts are preparing to provide screening for everyone between the ages of 40 to 74 from April 2009, but two teams of researchers have concluded the move will mean well-off men are overtreated with statins, while all women and less well-off male patients will miss out.

The researchers say that the Scottish ASSIGN tool would be far more effective than the Framingham score used in the screening programme at identifying risk in women and socially disadvantaged patients.

A study carried out in the University of Dundee and submitted to the BMJ concludes ASSIGN, which is commonly used in Scotland, is much fairer than Framingham. It reports that among poorer people, ASSIGN identifies 30% of men and 25% of women, versus 34% of men and 19% of women using Framingham.

Study leader Professor Hugh Tunstall-Pedoe, co-developer of ASSIGN and head of the cardiovascular epidemiology unit at the University of Dundee, believes ASSIGN should be used in England and Wales. Tunstall-Pedoe said "ASSIGN abolishes the social gradient in undertreatment of cardiovascular disease, whereas Framingham will be treating a lot of wealthy people who will not go on to develop CVD.'

Meanwhile, the independent evaluation for NICE of Framingham, ASSIGN and the QRISK score - obtained by Pulse under the Freedom of Information Act - also backs ASSIGN.

The study carried out by researchers from the University of East Anglia demonstrated that ASSIGN had better discrimination than Framingham and QRISK and should be considered as an 'alternative model' for CVD risk assessment.

Click here to view the full article online.

About PulseToday

PulseToday is the GP's website in the UK providing general practice news, clinical education and practice information to GPs and primary care staff.

You can register on this site to get access to further information by visiting:
www.pulsetoday.co.uk/subscribemenu.asp

Written by Christian Nordqvist
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today

Visit our vascular section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Christian Nordqvist. "UK Government's Vascular Screening Programme's Flaws." Medical News Today. MediLexicon, Intl., 1 Mar. 2009. Web.
12 Feb. 2012. <http://www.medicalnewstoday.com/articles/140662.php>

APA
Christian Nordqvist. (2009, March 1). "UK Government's Vascular Screening Programme's Flaws." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/articles/140662.php.

Please note: If no author information is provided, the source is cited instead.




Vascular

Most Popular Articles



Follow Our Vascular News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Vascular Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »